MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 66 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $11,814 | -21.2% | 23,628 | -0.0% | 0.00% | – |
Q3 2022 | $15,000 | -34.8% | 23,638 | -17.5% | 0.00% | – |
Q2 2022 | $23,000 | +15.0% | 28,636 | -0.4% | 0.00% | – |
Q1 2022 | $20,000 | -33.3% | 28,749 | -2.8% | 0.00% | – |
Q4 2021 | $30,000 | -23.1% | 29,569 | -2.3% | 0.00% | – |
Q3 2021 | $39,000 | -94.5% | 30,278 | -96.7% | 0.00% | -100.0% |
Q2 2021 | $713,000 | -30.6% | 920,637 | -5.9% | 0.00% | 0.0% |
Q1 2021 | $1,027,000 | -26.0% | 977,958 | -4.2% | 0.00% | -50.0% |
Q4 2020 | $1,388,000 | +53.0% | 1,020,435 | -13.8% | 0.00% | +100.0% |
Q3 2020 | $907,000 | -3.8% | 1,183,208 | -3.0% | 0.00% | 0.0% |
Q2 2020 | $943,000 | -79.8% | 1,220,332 | -84.3% | 0.00% | -75.0% |
Q1 2020 | $4,674,000 | +50.4% | 7,786,454 | +468.9% | 0.00% | 0.0% |
Q4 2019 | $3,107,000 | +197.0% | 1,368,630 | -17.5% | 0.00% | +300.0% |
Q3 2019 | $1,046,000 | -25.3% | 1,659,439 | +1.5% | 0.00% | -66.7% |
Q2 2019 | $1,401,000 | -25.0% | 1,634,970 | -4.5% | 0.00% | -25.0% |
Q1 2019 | $1,867,000 | – | 1,712,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,923,000 | $509,990 | 0.12% |
Arkadios Wealth Advisors | 1,399,000 | $181,870 | 0.02% |
NEVILLE RODIE & SHAW INC | 1,157,332 | $150 | 0.01% |
Platform Technology Partners | 162,410 | $21,113 | 0.01% |
JTC Employer Solutions Trustee Ltd | 775,000 | $101 | 0.01% |
Main Street Financial Solutions, LLC | 400,826 | $52,107 | 0.01% |
National Wealth Management Group, LLC | 42,750 | $5,558 | 0.01% |
STALEY CAPITAL ADVISERS INC | 400,000 | $52,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 754,732 | $98,115 | 0.00% |
HYMAN CHARLES D | 79,800 | $10,000 | 0.00% |